Diagnosis, Therapy and Control of Diabetes Mellitus in Children and Adolescents

 

 Buy Article Permissions and Reprints

Concerns and Background

The following recommendations are directed to all professional and vocational groups which take care of and support children and adolescents with diabetes, as well as their families. It is also directed to higher level organisations, such as health insurers, which deal with diabetes. This guideline concentrates on the specifics for this age group which are not described in the DDG’s general guidelines for the therapy of type 1 diabetes, or are described there, but somewhat differently [1].

As stated in the specifications of the health ministries of Germany’s states and in keeping with the current practice of many clinics, this paediatric guideline applies to all diabetes patients who are not yet 18 years of age. In individual clinical cases this guideline can also be used for young adults.

• References

• 1 Scherbaum WA, Kerner W. Evidenzbasierte Leitlinie der DDG – Therapie des Diabetes mellitus Typ 1. In: Martin S, Dreyer M, Kiess W, Lüdecke HJ, Müller UA, Schatz W. Deutsche Diabetes Gesellschaft (DDG); 2007
  Google Scholar
• 2 Neu A, Willasch A, Ehehalt S et al. Prävalenz und Altersverteilung des Diabetes mellitus im Kindesalter in Deutschland. Monatsschr Kinderheilkd 2002; 150: 196-200
  CrossrefPubMedGoogle Scholar
• 3 Rosenbauer J, Icks A, Grabert M et al. Hohe Prävalenz des Typ-1-Diabetes mellitus im Kindes- und Jugendalter in Deutschland (Abstract). Kinder-Jugendmed 2002; 2
  PubMedGoogle Scholar
• 4 Ehehalt S, Blumenstock G, Willasch AM et al. Continuous rise in incidence of childhood Type 1 diabetes in Germany. Diabet Med 2008; 25: 755-757
  CrossrefPubMedGoogle Scholar
• 5 Neu A, Ehehalt S, Willasch A et al. Rising incidence of type 1 diabetes in Germany: 12-year trend analysis in children 0–14 years of age. Diabetes Care 2001; 24: 785-786
  CrossrefPubMedGoogle Scholar
• 6 Rosenbauer J, Icks A, Schmitter D et al. Incidence of childhood Type I diabetes mellitus is increasing at all ages in Germany. Diabetologia 2002; 45: 457-458
  CrossrefPubMedGoogle Scholar
• 7 Kurth BM, Schaffrath RA. Die Verbreitung von Übergewicht und Adipositas bei Kindern und Jugendlichen in Deutschland. Ergebnisse des bundesweiten Kinder- und Jugendgesundheitssurveys (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 736-743
  CrossrefPubMedGoogle Scholar
• 8 Kromeyer-Hauschild K, Wabitsch M, Kunze D et al. Perzentile für den Body-Mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001; 149: 807-818
  CrossrefPubMedGoogle Scholar
• 9 Rosenbauer J, Icks A, duPrel JB et al. Populationsbasierte Daten zur Inzidenz des Typ-2-Diabetes mellitus bei Kindern und Jugendlichen in Deutschland. Monatsschr Kinderheilkd 2003; 151: 71
  PubMedGoogle Scholar
• 10 Neu A, Feldhahn L, Ehehalt S et al. Prevalence of type 2 diabetes and MODY in children and adolescents. A state-wide study in Baden-Wuerttemberg (Germany). Pediatr Diabetes 2005; 6: 27-28
  PubMedGoogle Scholar
• 11 Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC). Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005; EK IV
  PubMedGoogle Scholar
• 12 Gale EA, Gillespie KM. Diabetes and gender. Diabetologia 2001; 44: 3-15
  CrossrefPubMedGoogle Scholar
• 13 Rosenbloom AL, Schatz DA, Krischer JP et al. Therapeutic controversy: prevention and treatment of diabetes in children. J Clin Endocrinol Metab 2000; 85: 494-522
  CrossrefPubMedGoogle Scholar
• 14 Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005; EK I b
  PubMedGoogle Scholar
• 15 Arbeitsgemeinschaft Adipositas im Kindes- und Jugendalter (AGA). Leitlinien. Verabschiedet auf der Konsensus-Konferenz der AGA am 06.10.2008. Deutsche Adipositas-Gesellschaft; 2008
  PubMedGoogle Scholar
• 16 Bangstad HJ, Danne T, Deeb LC et al. Insulin treatment. ISPAD clinical practice consensus guidelines 2006–2007. Pediatr Diabetes 2007; 8: 88-102
  PubMedGoogle Scholar
• 17 Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC). Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005 EK II b-III
  PubMedGoogle Scholar
• 18 Rewers M, Pihoker C, Donaghue K et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 2007; 8: 408-418
  CrossrefPubMedGoogle Scholar
• 19 Cranston I, Lomas J, Maran A et al. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994; 344: 283-287
  CrossrefPubMedGoogle Scholar
• 20 Holl RW, Heinze E. Dawn- oder Somogyi-Phänomen? Hohemorgendliche Nüchternblutzuckerwerte bei jugendlichen Typ-1-Diabetikern. Dtsch MedWochenschr 1992; 117: 1503-1507
  PubMedGoogle Scholar
• 21 Hellems MA, Clarke WL. Safe at school: a Virginia experience. Diabetes Care 2007; 30: 1396-1398
  CrossrefPubMedGoogle Scholar
• 22 American Diabetes Association (ADA). Diabetes care in the school and day care setting. Diabetes Care 2007; 30 (Suppl. 01) S66-S73
  CrossrefPubMedGoogle Scholar
• 23 Nakhla M, Daneman D, Frank M et al. Translating transition: a critical review of the diabetes literature. J Pediatr Endocrinol Metab 2008; 21: 507-516
  PubMedGoogle Scholar
• 24 Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC). Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005
  PubMedGoogle Scholar
• 25 Court JM, Cameron FJ, Berg-Kelly K et al. Diabetes in adolescence. Pediatr Diabetes 2008; 9: 255-262
  CrossrefPubMedGoogle Scholar
• 26 Brink S, Laffel L, Likitmaskul S et al. Sick day management in children and adolescents with diabetes. Pediatr Diabetes 2007; 8: 401-407
  CrossrefPubMedGoogle Scholar
• 27 Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995; 44: 968-983
  CrossrefPubMedGoogle Scholar
• 28 White NH, Sun W, Cleary PA et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol 2008; 126: 1707-1715
  CrossrefPubMedGoogle Scholar
• 29 Nathan DM, Cleary PA, Backlund JY et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-2653
  CrossrefPubMedGoogle Scholar
• 30 Musen G, Jacobson AM, Ryan CM et al. Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial. Diabetes Care 2008; 31: 1933-1938
  CrossrefPubMedGoogle Scholar
• 31 Bangstad HJ, Danne T, Deeb LC et al. Insulin treatment. ISPAD clinical practice consensus guidelines 2006–2007. Pediatr Diabetes 2007; 8: 88-102
  PubMedGoogle Scholar
• 32 Danne T, Becker RH, Heise T et al. Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes. Diabetes Care 2005; 28: 2100-2105
  CrossrefPubMedGoogle Scholar
• 33 Mortensen HB, Lindholm A, Olsen BS et al. Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes. Eur J Pediatr 2000; 159: 483-488
  CrossrefPubMedGoogle Scholar
• 34 Deeb LC, Holcombe JH, Brunelle R et al. Insulin lispro lowers postprandial glucose in prepubertal children with diabetes. Pediatrics 2001; 108: 1175-1179
  CrossrefPubMedGoogle Scholar
• 35 Plank J, Siebenhofer A, Berghold A et al. Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus. Arch Intern Med 2005; 165: 337-344
  PubMedGoogle Scholar
• 36 Simpson D, McCormack PL, Keating GM et al. Insulin lispro: a review of its use in the management of diabetes mellitus. Drugs 2007; 67: 407-434
  CrossrefPubMedGoogle Scholar
• 37 Danne T, Aman J, Schober E et al. A comparison of postprandial and preprandial administration of insulin as part in children and adolescents with type 1 diabetes. Diabetes Care 2003; 26: 2359-2364
  CrossrefPubMedGoogle Scholar
• 38 Danne T, Datz N, Endahl L et al. Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial. Pediatr Diabetes 2008; 9: 554-560
  CrossrefPubMedGoogle Scholar
• 39 Thisted H, Johnsen SP, Rungby J. An update on the long-acting insulin analogue glargine. Basic Clin Pharmacol Toxicol 2006; 99: 1-11
  PubMedGoogle Scholar
• 40 Robertson KJ, Schoenle E, Gucev Z et al. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes. Diabet Med 2007; 24: 27-34
  CrossrefPubMedGoogle Scholar
• 41 Phillip M, Battelino T, Rodriguez H et al. Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007; 30: 1653-1662
  CrossrefPubMedGoogle Scholar
• 42 Aslander-van Vliet E, Smart C et al. Nutritional management in childhood and adolescent diabetes. Pediatr Diabetes 2007; 8: 323-339
  CrossrefPubMedGoogle Scholar
• 43 Mann J, de Leeuw I, Hermansen K et al. Evidenz-basierte Ernährungsempfehlungen zur Behandlung und Prävention des Diabetes mellitus. Diabet Stoffw 2005; 14: 75-94
  PubMedGoogle Scholar
• 44 Deutsche Gesellschaft für Ernährung (DGE), Österreichische Gesellschaft für Ernährung (ÖGE), Schweizerische Gesellschaft für Ernährungsforschung (SGE), Schweizerische Vereinigung für Ernährung (SVE). Referenzwerte für die Nährstoffzufuhr. Neustadt/Weinstraße: Neuer Umschau Buchverl; 2008
  Google Scholar
• 45 Bloomgarden ZT, Karmally W, Metzger MJ et al. Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diabetes Care 1987; 10: 263-272
  CrossrefPubMedGoogle Scholar
• 46 deWeerdt I, Visser AP, Kok GJ et al. Randomized controlled multicentre evaluation of an education programme for insulin-treated diabetic patients: effects on metabolic control, quality of life, and costs of therapy. Diabet Med 1991; 8: 338-345
  CrossrefPubMedGoogle Scholar
• 47 Lange K, Sassmann H, von Schütz W et al. Prerequisites for age-appropriate education in type 1 diabetes: a model programme for paediatric diabetes education in Germany. Pediatr Diabetes 2007; 8 (Suppl. 06) 63-71
  CrossrefPubMedGoogle Scholar
• 48 Swift PG. Diabetes education. ISPAD clinical practice consensus guidelines 2006–2007. Pediatr Diabetes 2007; 8: 103-109
  CrossrefPubMedGoogle Scholar
• 49 Mensing C, Boucher J, Cypress M et al. National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care 2000; 23: 682-689
  CrossrefPubMedGoogle Scholar
• 50 Funnell MM, Brown TL, Childs BP et al. National standards for diabetes self-management education. Diabetes Care 2009; 32 (Suppl. 01) S87-S94
  CrossrefPubMedGoogle Scholar
• 51 Bundesarbeitsgemeinschaft für Rehabilitation (BAR). Gemeinsames Rahmenkonzept der Gesetzlichen Krankenkassen und der Gesetzlichen Rentenversicherung für die Durchführung stationärer medizinischer Leistungen der Vorsorge und Rehabilitation für Kinder und Jugendliche. 2008 http://http://www.bar-frankfurt.de/upload/Rahmenkonzept.72dpi_435.pdf
  PubMedGoogle Scholar
• 52 Fröhlich C, Hermann T, Koch S et al. Indikationen für eine stationäre Rehabilitation von Kindern und Jugendlichen mit Typ-1-Diabetes – eine bundesweite „DPV-Wiss“-Analyse. Diabet Stoffw 2008; 93
  PubMedGoogle Scholar
• 53 Verband Deutscher Rentenversicherungsträger (VDR). Rahmenkonzept zur medizinischen Rehabilitation von Kindern und Jugendlichen in der gesetzlichen Rentenversicherung. Empfehlungen des Verbandes Deutscher Rentenversicherungsträger. 1998 http://http://infomed.mds-ev.de/sindbad.nsf/f79a8096ad98496fc12571e700442be0/3ccf1982457e68f080256bc4003b2fa3/$FILE/ATTS1QCV/VDR_KiJu-Reha_1998.pdf
  PubMedGoogle Scholar
• 54 Deutsche Gesellschaft für pädiatrische Rehabilitation und Prävention. Leitlinie Rehabilitation Diabetes mellitus im Kindes- und Jugendalter. 2007 http://http://www.uni-duesseldorf.de/awmf/ll/070-003.htm
  PubMedGoogle Scholar
• 55 Stachow R, Koch S, Fröhlich C et al. Effekte der stationären Rehabilitation von Kindern und Jugendlichen mit Diabetes mellitus Typ 1 – eine multizentrische DPV-Wiss-Analyse. Diabet Stoffw 2008; 59
  PubMedGoogle Scholar
• 56 Stachow R, Schultz A, Kurzinsky U et al. Anti-Streß-Training für Kinder und Jugendliche mit Diabetes während der stationären Rehabilitation. Kindheit Entwicklung 2001; 10: 226-239
  CrossrefPubMedGoogle Scholar
• 57 Delamater AM. Psychological care of children and adolescents with diabetes. Pediatr Diabetes 2007; 8: 340-348
  CrossrefPubMedGoogle Scholar
• 58 Forsander G, Persson B, Sundelin J et al. Metabolic control in children with insulin-dependent diabetes mellitus 5y after diagnosis. Early detection of patients at risk for poor metabolic control. Acta Paediatr 1998; 87: 857-864
  CrossrefPubMedGoogle Scholar
• 59 Hürter A, Otten A. Familien mit diabetischen Kindern und Jugendlichen: Psychische und soziale Probleme und der Wunsch nach psychologischer Hilfe im Vergleich mit anderen chronischen Erkrankungen. In: Roth R, Borkenstein M, eds. Psychosoziale Aspekte in der Betreuung von Kindern und Jugendlichen mit Diabetes. Basel: Karger; 1991: 150-159
  CrossrefGoogle Scholar
• 60 Sundelin J, Forsander G, Mattson SE. Family-oriented support at the onset of diabetes mellitus: a comparison of two group conditions during 2 years following diagnosis. Acta Paediatr 1996; 85: 49-55
  PubMedGoogle Scholar
• 61 Delamater AM, Bubb J, Davis SG et al. Randomized prospective study of self-management training with newly diagnosed diabetic children. Diabetes Care 1990; 13: 492-498
  CrossrefPubMedGoogle Scholar
• 62 Rydall AC, Rodin GM, Olmsted MP et al. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med 1997; 336: 1849-1854
  CrossrefPubMedGoogle Scholar
• 63 Bryden KS, Neil A, Mayou RA et al. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care 1999; 22: 1956-1960
  CrossrefPubMedGoogle Scholar
• 64 Nielsen S, Emborg C, Molbak AG. Mortality in concurrent type 1 diabetes and anorexia nervosa. Diabetes Care 2002; 25: 309-312
  CrossrefPubMedGoogle Scholar
• 65 Meltzer LJ, Johnson SB, Prine JM et al. Disordered eating, body mass, and glycemic control in adolescents with type 1 diabetes. Diabetes Care 2001; 24: 678-682
  CrossrefPubMedGoogle Scholar
• 66 Colton P, Olmsted M, Daneman D et al. Disturbed eating behavior and eating disorders in preteen and early teenage girls with type 1 diabetes: a case-controlled study. Diabetes Care 2004; 27: 1654-1659
  CrossrefPubMedGoogle Scholar
• 67 Liss DS, Waller DA, Kennard BD et al. Psychiatric illness and family support in children and adolescents with diabetic ketoacidosis: a controlled study. J Am Acad Child Adolesc Psychiatry 1998; 37: 536-544
  CrossrefPubMedGoogle Scholar
• 68 Northam EA, Matthews LK, Anderson PJ et al. Psychiatric morbidity and health outcome in Type 1 diabetes – perspectives from a prospective longitudinal study. Diabet Med 2005; 22: 152-157
  CrossrefPubMedGoogle Scholar
• 69 Hood KK, Huestis S, Maher A et al. Depressive symptoms in children and adolescents with type 1 diabetes: association with diabetes-specific characteristics. Diabetes Care 2006; 29: 1389-1391
  CrossrefPubMedGoogle Scholar
• 70 Stewart SM, Rao U, Emslie GJ et al. Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus. Pediatrics 2005; 115: 1315-1319
  CrossrefPubMedGoogle Scholar
• 71 Lawrence JM, Standiford DA, Loots B et al. Prevalence and correlates of ressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatrics 2006; 117: 1348-1358
  CrossrefPubMedGoogle Scholar
• 72 Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC). Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005 EK III/IV
  PubMedGoogle Scholar
• 73 Glaser NS, Wootton-Gorges SL, Buonocore MH et al. Frequency of subclinical cerebral edema in children with diabetic ketoacidosis. Pediatr Diabetes 2006; 7: 75-80
  CrossrefPubMedGoogle Scholar
• 74 Fiordalisi I, Novotny WE, Holbert D et al. An 18-yr prospective study of pediatric diabetic ketoacidosis: an approach to minimizing the risk of brain herniation during treatment. Pediatr Diabetes 2007; 8: 142-149
  CrossrefPubMedGoogle Scholar
• 75 Wolfsdorf J, Craig ME, Daneman D et al. Diabetic ketoacidosis. Pediatr Diabetes 2007; 8: 28-43
  PubMedGoogle Scholar
• 76 Edge JA, Jakes RW, Roy Y et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia 2006; 49: 2002-2009
  CrossrefPubMedGoogle Scholar
• 77 Wolfsdorf J, Craig ME, Daneman D et al. Diabetic ketoacidosis. Pediatr Diabetes 2007; 8: 28-43
  PubMedGoogle Scholar
• 78 Hanas R, Lindgren F, Lindblad B. Diabetic ketoacidosis and cerebral oedema in Sweden – a 2-year paediatric population study. Diabet Med 2007; 24: 1080-1085
  CrossrefPubMedGoogle Scholar
• 79 Roberts MD, Slover RH, Chase HP. Diabetic ketoacidosis with intracerebral complications. Pediatr Diabetes 2001; 2: 109-114
  CrossrefPubMedGoogle Scholar
• 80 Franklin B, Liu J, Ginsberg-Fellner F. Cerebral edema and ophthalmoplegia reversed by mannitol in a new case of insulin-dependent diabetes mellitus. Pediatrics 1982; 69: 87-90
  PubMedGoogle Scholar
• 81 Banks CJ, Furyk JS. Review article: hypertonic saline use in the emergency department. Emerg Med Australas 2008; 20: 294-305
  CrossrefPubMedGoogle Scholar
• 82 Clarke W, Jones T, Rewers A et al. Assessment and management of hypoglycaemia in children and adolescents with diabetes. Pediatr Diabetes 2008; 9: 165-174
  CrossrefPubMedGoogle Scholar
• 83 Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994; 125: 177-188
  CrossrefPubMedGoogle Scholar
• 84 Bangstad HJ, Danne T, Deeb LC et al. Insulin treatment. ISPAD clinical practice consensus guidelines 2006–2007. Pediatr Diabetes 2007; 8: 88-102
  PubMedGoogle Scholar
• 85 Silverstein J, Klingensmith G, Copeland K et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005; 28: 186-212
  CrossrefPubMedGoogle Scholar
• 86 Hill ID, Dirks MH, Liptak GS et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005; 40: 1-19
  CrossrefPubMedGoogle Scholar
• 87 Silverstein J, Klingensmith G, Copeland K et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005; 28: 186-212
  CrossrefPubMedGoogle Scholar
• 88 Kordonouri O, Maguire AM, Knip M et al. ISPAD Clinical Practice Consensus Guidelines 2006–2007. Other complications and associated conditions. Pediatr Diabetes 2007; 8: 171-176
  CrossrefPubMedGoogle Scholar
• 89 Hansen D, Brock-Jacobsen B, Lund E et al. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years‘ follow-up. Diabetes Care 2006; 29: 2452-2456
  CrossrefPubMedGoogle Scholar
• 90 Amin R, Murphy N, Edge J et al. A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes Care 2002; 25: 1117-1122
  CrossrefPubMedGoogle Scholar
• 91 Lewis HM, Renaula TL, Garioch JJ et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996; 135: 363-367
  CrossrefPubMedGoogle Scholar
• 92 Genuth S, Alberti KG, Bennett P et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167
  CrossrefPubMedGoogle Scholar
• 93 Alberti G, Zimmet P, Shaw J et al. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 2004; 27: 1798-1811
  CrossrefPubMedGoogle Scholar
• 94 UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group Lancet 1998; 352: 837-853
  CrossrefPubMedGoogle Scholar
• 95 Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589
  CrossrefPubMedGoogle Scholar
• 96 Shimazaki T, Kadowaki T, Ohyama Y et al. Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital. Transl Res 2007; 149: 196-204
  CrossrefPubMedGoogle Scholar
• 97 UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). . UK Prospective Diabetes Study (UKPDS) Group Lancet 1998; 352: 854-865
  CrossrefPubMedGoogle Scholar
• 98 Jones KL, Arslanian S, Peterokova VA et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2002; 25: 89-94
  CrossrefPubMedGoogle Scholar
• 99 Gottschalk M, Danne T, Vlajnic A et al. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. Diabetes Care 2007; 30: 790-794
  CrossrefPubMedGoogle Scholar
• 100 Ellard S, Bellanne-Chantelot C, Hattersley AT. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008; 51: 546-553
  CrossrefPubMedGoogle Scholar
• 101 Badenhoop K, Kordonouri O, Machicao F. Empfehlungen zur molekulargenetischen Diagnostik bei Verdacht auf MODY. DDG 2008;
  PubMedGoogle Scholar
• 102 Hattersley A, Bruining J, Shield J et al. ISPAD Clinical Practice Consensus Guidelines 2006–2007. The diagnosis and management of monogenic diabetes in children. Pediatr Diabetes 2006; 7: 352-360
  CrossrefPubMedGoogle Scholar
• 103 Flanagan SE, Edghill EL, Gloyn AL et al. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 2006; 49: 1190-1197
  CrossrefPubMedGoogle Scholar
• 104 Babenko AP, Polak M, Cave H et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl JMed 2006; 355: 456-466
  CrossrefPubMedGoogle Scholar
• 105 Klupa T, Kowalska I, Wyka K et al. Mutations in the ABCC8 gene are associated with a variable clinical phenotype. Clin Endocrinol (Oxf) 2008;
  PubMedGoogle Scholar
• 106 Lanng S, Thorsteinsson B, Lund-Andersen C et al. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 1994; 83: 72-77
  PubMedGoogle Scholar
• 107 Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis M. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr 2001; 90: 515-519
  CrossrefPubMedGoogle Scholar
• 108 Rolon MA, Benali K, Munck A et al. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001; 90: 860-867
  CrossrefPubMedGoogle Scholar
• 109 Dobson L, Hattersley AT, Tiley S et al. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child 2002; 87: 430-431
  CrossrefPubMedGoogle Scholar
• 110 O'Riordan SM, Robinson PD, Donaghue KC et al. Management of cystic fibrosis-related diabetes. Pediatr Diabetes 2008; 9: 338-344
  CrossrefPubMedGoogle Scholar
• 111 Man SA, Andre JL, de Bachmann H et al. Blood pressure in childhood: pooled findings of six European studies. J Hypertens 1991; 9: 109-114b
  CrossrefPubMedGoogle Scholar